Clinical trials: Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
- Condition Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
No studies match all of these filters
Remove a filter, check the spelling of a condition or drug, or try a broader term: “lung cancer” rather than a subtype.